Synthetic Peptides as Therapeutic Agents: Lessons Learned From Evolutionary Ancient Peptides and Their Transit Across Blood-Brain Barriers
- PMID: 31781029
- PMCID: PMC6861216
- DOI: 10.3389/fendo.2019.00730
Synthetic Peptides as Therapeutic Agents: Lessons Learned From Evolutionary Ancient Peptides and Their Transit Across Blood-Brain Barriers
Abstract
Peptides play a major role in the transmission of information to and from the central nervous system. However, because of their structural complexity, the development of pharmacological peptide-based therapeutics has been challenged by the lack of understanding of endogenous peptide evolution. The teneurin C-terminal associated peptides (TCAP) possess many of the required attributes of a practical peptide therapeutic. TCAPs, associated with the teneurin transmembrane proteins that bind to the latrophilins, members of the Adhesion family of G-protein-coupled receptors (GPCR). Together, this ligand-receptor unit plays an integral role in synaptogenesis, neurological development, and maintenance, and is present in most metazoans. TCAP has structural similarity to corticotropin-releasing factor (CRF), and related peptides, such as calcitonin and the secretin-based peptides and inhibits the (CRF)-associated stress response. Latrophilins are structurally related to the secretin family of GPCRs. TCAP is a soluble peptide that crosses the blood-brain barrier and regulates glucose transport into the brain. We posit that TCAP represents a phylogenetically older peptide system that evolved before the origin of the CRF-calcitonin-secretin clade of peptides and plays a fundamental role in the regulation of cell-to-cell energy homeostasis. Moreover, it may act as a phylogenetically older peptide system that evolved as a natural antagonist to the CRF-mediated stress response. Thus, TCAP's actions on the CNS may provide new insights into the development of peptide therapeutics for the treatment of CNS disorders.
Keywords: CRF; G-protein coupled receptors; blood-brain barrier; latrophilin; neuroplasticity; receptor-ligand interaction; secretin; stress.
Copyright © 2019 Lovejoy, Hogg, Dodsworth, Jurado, Read, D'Aquila and Barsyte-Lovejoy.
Figures


Similar articles
-
Corticotropin-Releasing Factor: An Ancient Peptide Family Related to the Secretin Peptide Superfamily.Front Endocrinol (Lausanne). 2020 Aug 27;11:529. doi: 10.3389/fendo.2020.00529. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32973673 Free PMC article.
-
Role of Teneurin C-Terminal Associated Peptides (TCAP) on Intercellular Adhesion and Communication.Front Neurosci. 2022 May 2;16:868541. doi: 10.3389/fnins.2022.868541. eCollection 2022. Front Neurosci. 2022. PMID: 35585927 Free PMC article. Review.
-
Teneurins, TCAP, and latrophilins: roles in the etiology of mood disorders.Transl Neurosci. 2016 Feb 24;7(1):17-23. doi: 10.1515/tnsci-2016-0004. eCollection 2016. Transl Neurosci. 2016. PMID: 28123817 Free PMC article. Review.
-
Information Processing in Affective Disorders: Did an Ancient Peptide Regulating Intercellular Metabolism Become Co-Opted for Noxious Stress Sensing?Bioessays. 2020 Sep;42(9):e2000039. doi: 10.1002/bies.202000039. Epub 2020 Aug 7. Bioessays. 2020. PMID: 32767437
-
Teneurin C-terminal associated peptides (TCAP): modulators of corticotropin-releasing factor (CRF) physiology and behavior.Front Neurosci. 2013 Sep 17;7:166. doi: 10.3389/fnins.2013.00166. Front Neurosci. 2013. PMID: 24062636 Free PMC article. Review.
Cited by
-
Quantitative neuropeptide analysis by mass spectrometry: advancing methodologies for biological discovery.RSC Chem Biol. 2025 Jun 12;6(8):1214-1232. doi: 10.1039/d5cb00082c. eCollection 2025 Jul 30. RSC Chem Biol. 2025. PMID: 40529571 Free PMC article. Review.
-
Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.Int J Nanomedicine. 2020 Sep 11;15:6673-6688. doi: 10.2147/IJN.S257459. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32982226 Free PMC article.
-
Pharmacokinetics and Molecular Modeling Indicate nAChRα4-Derived Peptide HAEE Goes through the Blood-Brain Barrier.Biomolecules. 2021 Jun 18;11(6):909. doi: 10.3390/biom11060909. Biomolecules. 2021. PMID: 34207317 Free PMC article.
-
Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae.ACS Omega. 2022 Aug 10;7(33):28797-28805. doi: 10.1021/acsomega.2c01614. eCollection 2022 Aug 23. ACS Omega. 2022. PMID: 36033708 Free PMC article.
-
Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.Biomedicines. 2022 Feb 1;10(2):343. doi: 10.3390/biomedicines10020343. Biomedicines. 2022. PMID: 35203552 Free PMC article. Review.
References
-
- Lovejoy DA. Neuroendocrinology: An Integrated Approach. Chichester: John Wiley & Sons Ltd; (2005).
-
- Kastin AJ, Pan W. Peptide transport across the blood-brain barrier. In: Prokai L, Prokai-Tatrai, editors. Progress in Drug Research. Vol 61 Basel: Birkahauser Verlag; (2003). p. 81–100. - PubMed
LinkOut - more resources
Full Text Sources